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Abstract
Objective
Acute or protracted cortical recording may be necessary for patients with drug-refractory
epilepsy to identify the ictogenic regions before undergoing resection. Currently, these invasive
recording techniques present certain limitations, one of which is the need for cables connecting
the recording electrodes placed in the intracranial space with external devices displaying the
recorded electrocorticographic signals. This equates to a direct connection between the sterile
intracranial space with the non-sterile environment. Due to the increasing likelihood of
infections with time, subdural grids are typically removed a few days after implantation, a
limiting factor in localizing the epileptogenic zone if seizures are not frequent enough to be
captured within this time-frame. Furthermore, patients are bound to stay in the hospital,
connected by the wires to the recording device, thus increasing substantially the treatment
costs. To address some of the current shortcomings of invasive monitoring, we developed a
neuroprosthesis made of a subdural silicone grid connected to a wireless transmitter allowing
prolonged electrocorticografic recording and direct cortical stimulation. This device consists of
a silicone grid with 128-platinum/iridium contacts, connected to an implantable case providing
wireless recording and stimulation. The case also houses a wirelessly rechargeable battery for
chronic long-term implants. We report the results of the first human proof-of-concept trial for
wireless transmission of electrocorticographic recordings using a device suited for long-term
implantation in three patients with drug-refractory epilepsy. 
Methods
Three patients with medically refractory epilepsy underwent the temporary intraoperative
placement of the subdural grid connected to the wireless device for recording and transmission
of electrocorticographic signals for a duration of five minutes before the conventional
recording electrodes were placed or the ictal foci were resected.
Results
Wireless transmission of brain signals was successfully achieved. The wireless
electrocorticographic signal was judged of excellent quality by a blinded neurophysiologist.
Conclusions
This preliminary experience reports the first successful placement of a wireless
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Introduction
Electrocorticography (ECoG) is a technique that allows the direct recording of brain electrical
activity from the cerebral cortex. Developed by Penfield and Jasper in the 1940, its use spans
from guiding resection of epileptogenic tissue in patients with drug-refractory epilepsy to
direct mapping of regions of the brain associated with essential functions (eloquent cortex)
such as movement, sensation, language comprehension and production in response to carefully
tailored stimuli. ECoG contacts can also allow direct electrical stimulation (DCS) of the human
brain, which represents the standard invasive method for cortical mapping in the context of the
resective brain surgery for brain tumors or other lesions encroaching eloquent cortex [1].
Mapping can be performed outside the surgical theatre with the patient fully awake, avoiding
the interference of anesthetic drugs on brain activity. Recently, the use of the ECoG signal has
also shown promising results in providing guide and feedback to robotic prostheses or
exoskeletons aiming to restore the mobility of patients who have lost sensorimotor function
due to conditions like spinal cord injury or brachial plexus [2-3]. Commercially available ECoG
systems are based on a grid-array of platinum or stainless steel electrodes embedded into one
or more sheets of a silastic material connected with an external amplifier through a shielded
cable. The cables leave the skull through a subcutaneous tunnel, thus providing a potential path
for cerebrospinal fluid (CSF) leak and consequent meningeal infection [4-6]. Infection is in fact
the most common complication related to the placement of subdural grids, especially if the
monitoring is extended beyond 10 days [6] . Due to the relationship between risk of infection
and recording duration, ECoG recording sessions are typically limited to one week.
Furthermore, patients undergoing invasive monitoring for epilepsy are confined into a
dedicated recording room under careful but necessarily short observation. At the end of the
monitoring period, the wound is re-opened and the grid removed. The relatively short duration
of most ECoG recording sessions can result in non-conclusive findings if not
enough representative seizures are captured. This limits a priori the number of patients to
whom ECoG can be offered based on seizure frequency or required medication tapering to
facilitate seizure occurrence. Based on these considerations, the use of cables connecting the
epicortical grid to an external device appears to be the most significant shortcoming of current
ECoG techniques. To address the above limitations, after a preliminary experience on primates,
we developed wireless fully implantable ECoG device characterized by 128 platinum-iridium
contacts placed on a silicon grid of sub-millimetric thickness and connected by intracranial
cables to a case made of polyetheretherketone (PEEK) allowing wireless transmission [3,7-8].
This device allows DCS through a set of 64 dedicated electrodes, while the other 64 electrodes
are used for signal acquisition only. The unique features of this neuroprosthesis include 1)
wireless data transmission of all the 64 acquisition channels recording in parallel, 2) wireless
direct cortical stimulation, and 3) wireless recharge by electromagnetic induction. The device
has been granted the following international patents: EP2699145 B1; US9031657 B2; JP6082942
B2; CA2832520 A; AU2012245942 B2; CN103648367 B. Data transmission exploits the recently
introduced Medical Implant Communication System (MICS), a low-power, short-range (2 m),
high-data-rate, 401-406 MHz (the core band is 402-405 104 MHz) communication network that
has been accepted worldwide for transmitting data to support the diagnostic or therapeutic
functions associated with medical implant devices [9]. This novel device was designed to allow
prolonged ECoG recording during invasive monitoring for several weeks/months, with
possibility for the patient to be discharged and safely monitored in its home environment.
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ECoG signals can be monitored real time by the involved physician and personnel, embodying a
novel development of telemedicine. The device can in theory also be used for a close-loop
responsive stimulation and for a wide range of brain computer interface (BCI) clinical
applications. Wireless ECoG acquisition using this new technique offers several clinical
advantages over conventional recording techniques: 1) the risk of CSF leaks and intracranial
infections is reduced; 2) prolonged recordings can be obtained; 3) remote home monitoring
with the patient discharged is possible. Prolonged recordings during regular daily life can
provide not only evidence of epileptic activity not shown by short-term monitoring, but
also show long-term seizure patterns not otherwise visible.
Materials And Methods
Patients
This study was conducted in patients scheduled for craniotomy surgery for their epilepsy. This
study was reviewed by the Surgical Innovations Committee of the University Health Network of
Toronto University and approval was obtained to investigate three patients. Patients gave
written informed consent to participate in the study. This study consisted of placing the
wireless transmitting grid on the surface of the cortex and wirelessly recording and
transmitting the ECoG for approximately five minutes. After this period, the wireless grid was
removed, and the operation proceeded as planned.
The Wireless Device ECoGI-64D 126
The “ECoGI-64D System” is an implantable brain diagnostic/stimulating device designed by
AB Medica to localize and monitor the activity of seizure foci in daily life for a prolonged time
(up to 30 days, with continuous recording for 24 hours a day) and to map the functional activity
of the brain by DCS before resection (Figure 1).
FIGURE 1: ECoGI-64D - the picture shows the subdural grid,
connecting cables and a wireless case
ECoG data are acquired from the cortical surface of the patient brain and transmitted to a radio
base station; an external computer with dedicated software provides control of data acquisition
and visualization. The external computer has also dedicated audio/video hardware and
software used to provide a synchronized video ECoG. The ECoGI-64D grid is composed of 64
acquisition and 64 stimulation electrodes (plus four reference electrodes), arranged in two
separable sections (Figure 2).
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FIGURE 2: The 128 contacts subdural grid hosting 64
recording and 64 stimulating contacts plus four ground
contacts
According to clinical needs, various sizes can be made. The grid described here measures 43 by 36
mm.
2019 Romanelli et al. Cureus 11(10): e5868. DOI 10.7759/cureus.5868 4 of 9
The grid can be split into two symmetric parts with 32 acquisition and 32 stimulation contacts
each plus two reference contacts. Electrodes are connected to an electronic board placed in an
airtight case housed in a compact biocompatible sealed PEEK enclosure. The electronic board
allows control, acquisition, and data communication. The antenna for communication, the coil
for wireless recharge and the battery for power supply are also placed inside the airtight case.
The electronic board contains an Analog to Digital front-end and a multiplexing module
allowing to choose the stimulation electrodes pair and a microcontroller for device
management. A radio link module sends the data to the external unit (Radio Base Station) by
MICS radio signals (Medical Implant Communication Service-MICS: 402 to 405 MHz band). The
microcontroller software can be upgraded remotely, providing further flexibility to the system.
Wireless recharge is provided by magnetic induction through a dedicated device according to
the international WPC (Wireless Power Consortium) standard. Overheating during the recharge
procedure is prevented by the ECoG proprietary algorithm, which receives continuous feedback
about the skin temperature above the PEEK case. The device is compliant with all the
requirements of European Directives for Active Implantable Medical Devices, applicable to the
cortical recording for pre-surgical evaluation of epilepsy in humans, considering all the
constraints of an implantable medical device like ultra-low power, miniaturization, safety,
reliability and regulatory requirements applicable. Further technical details are described in
previously published papers [3,7-8]. 
Evaluation of the Intracranial Electroencephalogram
The acquired signal was submitted for blind review to a specialist clinical
neurophysiologist (SS) who evaluated the suitability of the data for the clinical interpretation
and for localization of interictal epileptiform activity. The latter was compared with that
identified in the dataset acquired with a conventional intracranial grid.
Results
Short-term wireless ECoG recordings were performed in three patients during the resective
epilepsy surgical procedures. Patient 1 had seizure onset at the age of 10 years. A left temporal
arachnoid cyst was detected and drained, after which the patient remained seizure-free for
eight years. At the age of 24 years, due to recurrent drug-refractory seizures, a left anterior
temporal lobectomy was performed but seizure control was not achieved. At the time of
referral, the patient was on levetiracetam, lamotrigine, and methylphenidate. Scalp video-
electroencephalogram (EEG) telemetry showed ictal activity in the left posterior quadrant. To
precisely outline the extent of the epileptogenic zone, the patient underwent an extension of a
previous craniotomy under general anesthesia and the EcoG recording. The dura was opened,
and the prototype grid was placed on the temporal neocortex, the basal temporal neocortex,
and the superior temporal gyrus. Interictal ECoG signals were recorded and wirelessly
transmitted for five minutes. Figure 3 shows a screenshot of the wireless ECoG with interictal
epileptic activity from this patient. After the wireless recording was completed, the device was
removed and replaced by a conventional grid for diagnostic invasive monitoring. A week later,
the patient underwent removal of the implanted grid and microsurgical resection of the inferior
temporal gyrus. He has been seizure-free since the surgery. Patient 2 had an onset of complex
partial seizures at the age of 18 due to right temporo-mesial cavernoma. Functional MRI
studies identified a left hemisphere dominance for language. After conventional EEG
monitoring, the patient was offered right anterior temporal lobectomy
plus amygdalohippocampectomy including removal of the cavernoma. A suitable temporal
craniotomy was performed, the dura was opened and the Sylvian fissure was identified. The
prototype grid was placed on the temporal lobe for short-term (five minutes) recording. Wireless
transmission of ECoG signals before the resection of cavernoma and the adjacent amygdala,
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hippocampus, and parahippocampal gyrus was conducted. The patient remains seizure-free
six months after the procedure. Patient 3 had a history of developmental delay (IQ = 61) and
schizophrenia; seizure onset was at 16 years of age. MRI was suggestive for left mesial
temporal sclerosis. Video-EEG telemetry had captured typical seizures compatible with a left
temporal lobe onset. Resective surgery was offered. The patient underwent temporal
craniotomy and placement of the grid with five minutes of ECoG wireless transmission before
undergoing left anterior temporal lobectomy and amygdalohippocampectomy. The patient has
been seizure-free for four months at the time of this manuscript submission. In all three cases,
the grid was easily placed on the brain and wireless ECoG transmission performed. The ECoG
data were considered fully interpretable by the blinded expert (SS) and localization on interictal
EEG abnormalities was concordant with that of the traditional grid and could have effectively
directed the resection if used alone. The wireless ECoG quality was considered equivalent to
that of traditional wired ECoG. In all three cases, wireless ECoG localized interictal spikes
concordant with presurgical data and with subsequent wired recordings. No device-related
complication was observed. 
FIGURE 3: Wireless ECoG screenshot showing interictal
spikes over the channels 35-37 (covering the inferior temporal
gyrus) in patient 1
Discussion
After preliminary experience on non-human primates, a wireless device for ECoG recording
in patients with drug-refractory epilepsy has been developed and tested on three patients
undergoing invasive monitoring for ictal focus localization. The data presented here builds
upon previous experiments in animals. The first prolonged recording with this chronic wireless
ECoG device was obtained in a non-human primate, positioning a 16-channel grid over the
sensorimotor cortex [3]. During this experiment, the impendence of each contact was found to
remain substantially below 10 KΩ over six months, thus indicating the integrity of the signal
acquisition. Wireless transmission of the ECoG signals maintained an excellent quality over
time as well. Somatosensory evoked potentials were acquired and DCS was performed at set
intervals as previously described [3,8]. Repeated somatotopic mapping of the primary motor
cortex by direct cortical stimulation was also achieved successfully throughout the course of
the experiment. Wireless recharge was provided by a custom-made recharging cage using a
patented recharging system (patents EP2755469 B; US9831709 B2; 210 CN104427864 B). The
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recharging cage allowed a seamless recharge process without any additive stress to the primate
who was allowed to move freely inside the cage throughout the entire duration of the
experiment [3,7]. Removal of the device at the end of the 6 months monitoring period was
remarkable for the total absence of adhesions between the grid and the cortex [3]. This
experience encouraged us to develop a wireless device intended for clinical
human applications, connected with a dedicated purpose-built 128 subdural grid, hosting 64
channels dedicated to monitoring and 64 channels to stimulation. Grid thickness is 0.5 mm
with an electrode thickness of 25 µm. The grid can be manufactured in a range of sizes (44 by
35 mm, 66 by 55 mm or 91 by 60 mm), allowing the sampling of more restricted or wider regions
of cortex. In this pilot human study, we used a 44 by 35 mm grid. The 128-channel
configuration was chosen because it represents the best compromise between spatial sampling,
associated data throughput and radio bandwidth used. Wireless data transfer exploits the
recently introduced Medical Implant Communication System (MICS), a communication
network that has been accepted worldwide for the transmission of diagnostic or therapeutic
medical data designed to support uni- or bi-directional data transfer from medical devices
implanted in the body to a programmer/controller outside [10]. MICS is characterized by a low-
power, short-range (up to 2 meters), high-data-rate transmission with a core band of 402 to 405
MHz with good conductivity in the human body. The frequency used reduces the risk
of interference with other devices and requires a transmission power limited to 25 microwatts.
The programmer/controller unit can in his turn transmit the data received by the implanted
device through existing communication networks, including the World Wide Web. With the
implanted device, ECoG signals can be visualized in real-time by the treating physician on a
smart-phone, tablet or dedicated laptop. The device is supplied by medical-grade certified
batteries, needing a daily wireless recharge, which is made possible by the use of a PEEK-case
allowing bidirectional wireless data transfer and recharge. Power transfer with battery recharge
is obtained by electromagnetic coupling between the coil integrated on the implanted device
and the one integrated on the wireless recharger. It is sufficient to place the wireless recharger
above the skin overlying the PEEK case to obtain the electromagnetic coupling and start the
power transfer. The wireless recharger provides visual and auditory signals: an auditory signal
indicates that the coupling between the two coils was obtained, thus allowing the start of the
recharge; a bicolor LED becomes green to signal a correct flow of energy and red if the coupling
is lost and no recharge is happening. An internal microprocessor interrupts automatically the
recharge phase if the temperature of the skin above the case increases by more than 2 °C, thus
preventing skin burns due to excessive heating. The device can be implanted under the scalp for
weeks or months, offering to patients undergoing invasive monitoring the advantage of
prolonged ECoG recording without an increasing risk of infection. The added flexibility of the
proposed device in terms of recording duration can enhance the probability of localizing the
ictal-onset zone and extend the indication for invasive monitoring to a wider group of patients
with drug-resistant epilepsy, which are today declined due to episodic seizures. These include
cases with non-daily or infrequent seizures, which are not offered the option of invasive
monitoring due to the limited chance of defining the ictal focus during the necessarily short
recording time. The wireless device here described provides an enhanced diagnostic medium to
localize neocortical ictal foci and can be used in adults and children, allowing early discharge
and home monitoring through a dedicated Video-EEG station. Furthermore, long-term
recordings can disclose seizure patterns not visible in the acute recordings done as an inpatient
who has recently undergone surgery under general anesthesia. Prolonged EcoG recording may
actually show rather surprising seizure patterns, including discordant lateralization of mesial
temporal lobe epilepsy [10]. There is also evidence that stable ECoG recording may require up
to 100 days to emerge after surgery [11]. Wireless transmission of ECoG recordings may in the
future not only be of diagnostic value but also provide therapeutic options by closed-loop
cortical stimulation. Closed-loop systems of neuromodulation may use wireless transmission of
recordings from subdural grid electrodes to trigger or alter cortical stimulation using
contacts on the grid itself. Remote sites of the central nervous system such as the thalamus and
basal ganglia or the spinal cord can be reached by a wireless pairing of the intracranial contacts
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with, respectively, deep brain stimulation or spinal cord stimulation electrodes. Wireless ECoG
recording is a promising technology for brain-computer interface (BCI) applications, with the
potential to guide neuroprosthetic limbs or exoskeletons [3,8]. Wireless technology can also
mitigate the need for tunneling of subcutaneous wires or extensions and therefore reduce the
risk for skin erosion, dislocation, and infection.
Conclusions
Short-term wireless ECoG monitoring was successfully performed in three patients
undergoing epilepsy surgery. After this preliminary experience, we look forward to achieving
prolonged wireless ECoG recording in selected patients. A fully implantable wireless ECoG
device can extend substantially the recording time, thus enhancing the chances to achieve
seizure focus localization while minimizing the risk of infections. Closed-loop stimulation and
BCI applications are other promising applications of wireless ECoG. 
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